Illinois Municipal Retirement Fund increased its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 35.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 122,352 shares of the company’s stock after acquiring an additional 31,890 shares during the quarter. Illinois Municipal Retirement Fund’s holdings in Henry Schein were worth $8,467,000 at the end of the most recent quarter.
A number of other institutional investors also recently bought and sold shares of HSIC. CIBC Asset Management Inc increased its stake in Henry Schein by 1.0% in the fourth quarter. CIBC Asset Management Inc now owns 17,849 shares of the company’s stock valued at $1,235,000 after purchasing an additional 169 shares during the period. Studio Investment Management LLC increased its stake in Henry Schein by 3.8% in the third quarter. Studio Investment Management LLC now owns 4,674 shares of the company’s stock valued at $341,000 after purchasing an additional 172 shares during the period. Central Pacific Bank Trust Division increased its stake in Henry Schein by 2.0% in the fourth quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company’s stock valued at $706,000 after purchasing an additional 200 shares during the period. Sanctuary Advisors LLC increased its stake in Henry Schein by 5.0% in the fourth quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company’s stock valued at $294,000 after purchasing an additional 203 shares during the period. Finally, Huntington National Bank increased its stake in Henry Schein by 16.8% in the third quarter. Huntington National Bank now owns 1,515 shares of the company’s stock valued at $110,000 after purchasing an additional 218 shares during the period. 96.62% of the stock is currently owned by institutional investors and hedge funds.
Henry Schein Stock Down 2.3 %
HSIC stock opened at $75.82 on Wednesday. The company has a market cap of $9.45 billion, a P/E ratio of 31.20, a P/E/G ratio of 2.13 and a beta of 0.91. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.63. The company’s 50-day moving average price is $74.25 and its 200 day moving average price is $72.43. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46.
Analyst Upgrades and Downgrades
A number of research analysts have commented on the stock. Barrington Research lifted their price objective on shares of Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a research note on Thursday, January 30th. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and lifted their target price for the company from $69.00 to $84.00 in a report on Monday, January 6th. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Mizuho started coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 target price on the stock. Finally, Jefferies Financial Group lifted their target price on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Eight equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, Henry Schein presently has an average rating of “Moderate Buy” and an average target price of $80.09.
Read Our Latest Stock Report on Henry Schein
Henry Schein Profile
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Read More
- Five stocks we like better than Henry Schein
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- The Most Important Warren Buffett Stock for Investors: His Own
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.